These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6785913)

  • 1. [Ultrastructural investigations on the effect of cyclophosphamide on experimental Trypanosoma cruzi infections (author's transl)].
    Hüther AM
    Tropenmed Parasitol; 1981 Mar; 32(1):51-4. PubMed ID: 6785913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi.
    Adade CM; Figueiredo RC; De Castro SL; Soares MJ
    Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.
    Umekita LF; Carneiro SM; Sesso A; Mota I
    J Parasitol; 1999 Oct; 85(5):867-72. PubMed ID: 10577722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro.
    Meirelles MN; de Araujo-Jorge TC; Miranda CF; de Souza W; Barbosa HS
    Eur J Cell Biol; 1986 Aug; 41(2):198-206. PubMed ID: 3093234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One fate of epimastigote forms of Trypanosoma cruzi injected in mice. An ultrastructural study.
    Umekita LF; Carneiro SM; Mota I
    J Parasitol; 1998 Dec; 84(6):1190-5. PubMed ID: 9920312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanocidal effects of promethazine.
    Fernández AR; Fretes R; Rubiales S; Lacuara JL; Paglini-Oliva P
    Medicina (B Aires); 1997; 57(1):59-63. PubMed ID: 9435371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism of Trypanosoma cruzi in the blood of a vertebrate host].
    Kallinikova VD; Donchenko TG
    Parazitologiia; 1985; 19(6):424-33. PubMed ID: 3937117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructural localization of peroxisomes in the blood forms of Trypanosoma cruzi (Chagas, 1909) using 3,3'-diaminobenzidine.
    Wartoń A; Modlińska M
    Bull Acad Pol Sci Biol; 1976; 24(10):611-3. PubMed ID: 65204
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study.
    De Carvalho EA; Andrade PP; Silva NH; Pereira EC; Figueiredo RC
    Micron; 2005; 36(2):155-61. PubMed ID: 15629646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
    Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lampit on Trypanosoma cruzi in mice organs and in the bloodstream.
    Villalta F; de Souza W; Leon W
    Z Parasitenkd; 1979; 61(1):21-7. PubMed ID: 120645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphism in trypomastigotes of Trypanosoma cruzi from blood and cell culture.
    Urdaneta-Morales S
    Tropenmed Parasitol; 1983 Dec; 34(4):225-8. PubMed ID: 6420964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
    Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection.
    Hideko Tatakihara VL; Cecchini R; Borges CL; Malvezi AD; Graça-de Souza VK; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):47-58. PubMed ID: 18031539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi.
    Sanchez AM; Jimenez-Ortiz V; Sartor T; Tonn CE; García EE; Nieto M; Burgos MH; Sosa MA
    Acta Trop; 2006 May; 98(2):118-24. PubMed ID: 16647030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An agent-based model for predicting the prevalence of Trypanosoma cruzi I and II in their host and vector populations.
    Devillers H; Lobry JR; Menu F
    J Theor Biol; 2008 Dec; 255(3):307-15. PubMed ID: 18805428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.